SCI vs VRTX · P/E 19, rev $4.31B vs P/E 30, rev $12.00B
Service Corporation International (SCI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Service Corporation International (SCI) is a personal services company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SCI revenue for 2025-12-31 was $4.31B. Net income was $542.6M. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SCI currently screens at market cap $10.01B and trailing P/E 19.1. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SCI and VRTX stock pages for the full models.
Not investment advice.